Technology tamfitronics
- Data & Views
- Printed:
Drug contain
Subject issues
A approach for establishing capsules that can even be quick neutralized is demonstrated for anticoagulants.
Right here’s a preview of subscription explain, access by strategy of your institution
Catch entry to alternate choices
Catch entry to Nature and 54 other Nature Portfolio journals
Catch Nature+, our easiest-designate on-line-access subscription
24,99 € / 30 days
atomize any time
Subscribe to this journal
Procure 12 print points and on-line access
214,86 € per year
only 17,91 € per field
Buy this article
- Buy on Springer Hyperlink
- Instantaneous access to plump article PDF
Prices could maybe be field to local taxes that are calculated at some level of checkout
References
-
Dockerill, M. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-024-02209-z (2024).
-
Hirsh, J., Anand, S. S., Halperin, J. L. & Fuster, V. Circulation 1032994–3018 (2001).
-
Brenner, S. & Lerner, R. A. Proc. Natl Acad. Know USA 895381–5383 (1992).
-
Melkko, S., Scheuermann, J., Dumelin, CE & Neri, D. Nat. Biotechnol. 22568–574 (2004).
-
Mannocci, L. et al. Proc. Natl Acad. Know USA 10517670–17675 (2008).
-
Gartner, ZJ et al. Science 3051601–1605 (2004).
-
Clark, MA et al. Nat. Chem. Biol. 5647–654 (2009).
-
Barluenga, S. & Winssinger, N. Acc. Chem. Res. Forty eight1319–1331 (2015).
Ethics declarations
Competing interests
D.N. is co-founder, CEO and shareholder of Philogen, a biotech company that works (among other things) in the discipline of DNA-encoded chemical libraries.
Rights and permissions
About this article
Cite this article
Neri, D. Designing capsules with reversible project. Nat Biotechnol (2024). https://doi.org/10.1038/s41587-024-02242-y
-
Printed:
-
DOI: https://doi.org/10.1038/s41587-024-02242-y
